We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Seeking Clues to Corteva, Inc. (CTVA) Q1 Earnings? A Peek Into Wall Street Projections for Key Metrics
Read MoreHide Full Article
Wall Street analysts expect Corteva, Inc. (CTVA - Free Report) to post quarterly earnings of $1.14 per share in its upcoming report, which indicates a year-over-year increase of 0.9%. Revenues are expected to be $4.65 billion, up 5.2% from the year-ago quarter.
The consensus EPS estimate for the quarter has undergone an upward revision of 1.4% in the past 30 days, bringing it to its present level. This represents how the covering analysts, as a whole, have reassessed their initial estimates during this timeframe.
Prior to a company's earnings announcement, it is crucial to consider revisions to earnings estimates. This serves as a significant indicator for predicting potential investor actions regarding the stock. Empirical research has consistently demonstrated a robust correlation between trends in earnings estimate revision and the short-term price performance of a stock.
While investors typically use consensus earnings and revenue estimates as a yardstick to evaluate the company's quarterly performance, scrutinizing analysts' projections for some of the company's key metrics can offer a more comprehensive perspective.
Given this perspective, it's time to examine the average forecasts of specific Corteva, Inc. metrics that are routinely monitored and predicted by Wall Street analysts.
The combined assessment of analysts suggests that 'Revenue- Seed' will likely reach $2.88 billion. The estimate suggests a change of +6.3% year over year.
Analysts' assessment points toward 'Revenue- Crop Protection' reaching $1.79 billion. The estimate indicates a change of +4.5% from the prior-year quarter.
Analysts expect 'Revenue- Crop Protection- Other' to come in at $121.64 million. The estimate indicates a change of -3.5% from the prior-year quarter.
The consensus estimate for 'Revenue- Seed- Other' stands at $120.77 million. The estimate points to a change of +9.8% from the year-ago quarter.
The average prediction of analysts places 'Revenue- Crop Protection- Herbicides' at $912.97 million. The estimate indicates a year-over-year change of +6.2%.
Based on the collective assessment of analysts, 'Revenue- Crop Protection- Insecticides' should arrive at $360.32 million. The estimate points to a change of +7.2% from the year-ago quarter.
Analysts predict that the 'Revenue- Crop Protection- Fungicides' will reach $324.07 million. The estimate indicates a change of +6.6% from the prior-year quarter.
It is projected by analysts that the 'Revenue- Seed- Soybean' will reach $320.25 million. The estimate points to a change of +5% from the year-ago quarter.
The consensus among analysts is that 'Revenue- Seed- Corn' will reach $2.18 billion. The estimate indicates a year-over-year change of +5.3%.
According to the collective judgment of analysts, 'Revenue- Seed- Other oilseeds' should come in at $251.15 million. The estimate suggests a change of +12.6% year over year.
The collective assessment of analysts points to an estimated 'Operating EBITDA- Seed' of $948.01 million. Compared to the present estimate, the company reported $842.00 million in the same quarter last year.
Analysts forecast 'Operating EBITDA- Crop Protection' to reach $369.09 million. The estimate is in contrast to the year-ago figure of $377.00 million.
Over the past month, shares of Corteva, Inc. have returned -5.3% versus the Zacks S&P 500 composite's +12.2% change. Currently, CTVA carries a Zacks Rank #3 (Hold), suggesting that its performance may align with the overall market in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .
Zacks' 7 Best Strong Buy Stocks (New Research Report)
Valued at $99, click below to receive our just-released report
predicting the 7 stocks that will soar highest in the coming month.
View the Zacks #1 Rank List
Image: Bigstock
Seeking Clues to Corteva, Inc. (CTVA) Q1 Earnings? A Peek Into Wall Street Projections for Key Metrics
Wall Street analysts expect Corteva, Inc. (CTVA - Free Report) to post quarterly earnings of $1.14 per share in its upcoming report, which indicates a year-over-year increase of 0.9%. Revenues are expected to be $4.65 billion, up 5.2% from the year-ago quarter.
The consensus EPS estimate for the quarter has undergone an upward revision of 1.4% in the past 30 days, bringing it to its present level. This represents how the covering analysts, as a whole, have reassessed their initial estimates during this timeframe.
Prior to a company's earnings announcement, it is crucial to consider revisions to earnings estimates. This serves as a significant indicator for predicting potential investor actions regarding the stock. Empirical research has consistently demonstrated a robust correlation between trends in earnings estimate revision and the short-term price performance of a stock.
While investors typically use consensus earnings and revenue estimates as a yardstick to evaluate the company's quarterly performance, scrutinizing analysts' projections for some of the company's key metrics can offer a more comprehensive perspective.
Given this perspective, it's time to examine the average forecasts of specific Corteva, Inc. metrics that are routinely monitored and predicted by Wall Street analysts.
The combined assessment of analysts suggests that 'Revenue- Seed' will likely reach $2.88 billion. The estimate suggests a change of +6.3% year over year.
Analysts' assessment points toward 'Revenue- Crop Protection' reaching $1.79 billion. The estimate indicates a change of +4.5% from the prior-year quarter.
Analysts expect 'Revenue- Crop Protection- Other' to come in at $121.64 million. The estimate indicates a change of -3.5% from the prior-year quarter.
The consensus estimate for 'Revenue- Seed- Other' stands at $120.77 million. The estimate points to a change of +9.8% from the year-ago quarter.
The average prediction of analysts places 'Revenue- Crop Protection- Herbicides' at $912.97 million. The estimate indicates a year-over-year change of +6.2%.
Based on the collective assessment of analysts, 'Revenue- Crop Protection- Insecticides' should arrive at $360.32 million. The estimate points to a change of +7.2% from the year-ago quarter.
Analysts predict that the 'Revenue- Crop Protection- Fungicides' will reach $324.07 million. The estimate indicates a change of +6.6% from the prior-year quarter.
It is projected by analysts that the 'Revenue- Seed- Soybean' will reach $320.25 million. The estimate points to a change of +5% from the year-ago quarter.
The consensus among analysts is that 'Revenue- Seed- Corn' will reach $2.18 billion. The estimate indicates a year-over-year change of +5.3%.
According to the collective judgment of analysts, 'Revenue- Seed- Other oilseeds' should come in at $251.15 million. The estimate suggests a change of +12.6% year over year.
The collective assessment of analysts points to an estimated 'Operating EBITDA- Seed' of $948.01 million. Compared to the present estimate, the company reported $842.00 million in the same quarter last year.
Analysts forecast 'Operating EBITDA- Crop Protection' to reach $369.09 million. The estimate is in contrast to the year-ago figure of $377.00 million.
View all Key Company Metrics for Corteva, Inc. here>>>Over the past month, shares of Corteva, Inc. have returned -5.3% versus the Zacks S&P 500 composite's +12.2% change. Currently, CTVA carries a Zacks Rank #3 (Hold), suggesting that its performance may align with the overall market in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .